Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers
Authors
Keywords
-
Journal
Scientific Reports
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-09-25
DOI
10.1038/srep14499
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer
- (2015) Tao Wang et al. Oncotarget
- Suppression of miR-184 in malignant gliomas upregulates SND1 and promotes tumor aggressiveness
- (2014) Luni Emdad et al. NEURO-ONCOLOGY
- Integrative investigation on breast cancer in ER, PR and HER2-defined subgroups using mRNA and miRNA expression profiling
- (2014) Xiaofeng Dai et al. Scientific Reports
- Radon-Induced Alterations in Micro-RNA Expression Profiles in Transformed BEAS2B Cells
- (2013) Feng-Mei Cui et al. JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES
- miR-135a/b Modulate Cisplatin Resistance of Human Lung Cancer Cell Line by Targeting MCL1
- (2013) Li Zhou et al. PATHOLOGY & ONCOLOGY RESEARCH
- Molecular and functional evolution of human DHRS2 and DHRS4 duplicated genes
- (2012) Franco Gabrielli et al. GENE
- Secreted protein, acidic and rich in cysteine-like 1 (SPARCL1) is down regulated in aggressive prostate cancers and is prognostic for poor clinical outcome
- (2012) P. J. Hurley et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer
- (2011) F. M. Buffa et al. CANCER RESEARCH
- KOBAS 2.0: a web server for annotation and identification of enriched pathways and diseases
- (2011) Chen Xie et al. NUCLEIC ACIDS RESEARCH
- The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
- (2010) David Warde-Farley et al. NUCLEIC ACIDS RESEARCH
- Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
- (2010) Fiona M. Blows et al. PLOS MEDICINE
- Activated leukocyte cell adhesion molecule: A novel biomarker for breast cancer
- (2009) Vathany Kulasingam et al. INTERNATIONAL JOURNAL OF CANCER
- Isolation of circulating epithelial and tumor progenitor cells with an invasive phenotype from breast cancer patients
- (2009) Janice Lu et al. INTERNATIONAL JOURNAL OF CANCER
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Predictive impact of activated leukocyte cell adhesion molecule (ALCAM/CD166) in breast cancer
- (2008) M. Ihnen et al. BREAST CANCER RESEARCH AND TREATMENT
- Gastrin-Releasing Peptide Receptor Imaging in Human Breast Carcinoma Versus Immunohistochemistry
- (2008) C. Van de Wiele et al. JOURNAL OF NUCLEAR MEDICINE
- NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer
- (2008) Rainer Fagerholm et al. NATURE GENETICS
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists
- (2008) Da Wei Huang et al. NUCLEIC ACIDS RESEARCH
- miRecords: an integrated resource for microRNA-target interactions
- (2008) F. Xiao et al. NUCLEIC ACIDS RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started